Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3914407
Max Phase: Preclinical
Molecular Formula: C13H18N4O2S
Molecular Weight: 294.38
Molecule Type: Small molecule
Associated Items:
ID: ALA3914407
Max Phase: Preclinical
Molecular Formula: C13H18N4O2S
Molecular Weight: 294.38
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSCC1CN(Cc2c[nH]c3c(=O)[nH]cnc23)CC1O
Standard InChI: InChI=1S/C13H18N4O2S/c1-20-6-9-4-17(5-10(9)18)3-8-2-14-12-11(8)15-7-16-13(12)19/h2,7,9-10,14,18H,3-6H2,1H3,(H,15,16,19)
Standard InChI Key: DBPWKRQKYPFTJB-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 294.38 | Molecular Weight (Monoisotopic): 294.1150 | AlogP: 0.41 | #Rotatable Bonds: 4 |
Polar Surface Area: 85.01 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.03 | CX Basic pKa: 7.91 | CX LogP: -0.13 | CX LogD: -0.76 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.76 | Np Likeness Score: -0.40 |
1. (2016) Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase, |
Source(1):